Actively Recruiting
Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis
Led by PT. Prodia Stem Cell Indonesia · Updated on 2026-02-27
15
Participants Needed
1
Research Sites
153 weeks
Total Duration
On this page
Sponsors
P
PT. Prodia Stem Cell Indonesia
Lead Sponsor
R
Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study was conducted to determine the effect of Umbilical Cord Mesenchymal Stem Cell (UC-MSC) and Secretome in severe ARDS patients. The study is a randomized control trial - double blind, which has 3 arms intervention namely, Control treatment, UC-MSC treatment, and UC-MSC and Secretome treatment.
CONDITIONS
Official Title
Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female at least 40 years old when the Informed Consent Form is signed by the family
- Patients with severe Acute Respiratory Distress Syndrome (ARDS) according to Berlin criteria
- Families willing to participate in clinical trial procedures and not join other clinical trials during participation
You will not qualify if you...
- Pregnant women confirmed by pregnancy test
- Liver enzyme (SGOT or SGPT) levels more than 5 times the normal upper limit
- Estimated glomerular filtration rate (eGFR) less than 30 ml/min or patients on routine hemodialysis
- Having more than two of these co-morbidities: hypertension, diabetes, chronic heart disease, chronic lung disease, COPD, asthma, tuberculosis, cancer, chronic kidney disease, immunosuppressive disease, HIV
- Blood lipid profile far above normal levels (cholesterol above 239 mg/dL)
- Abnormal PT APTT or C Peptide test results
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
RSPAD Gatot Soebroto
Jakarta Pusat, DKI Jakarta, Indonesia, 10410
Actively Recruiting
Research Team
D
Dewiyana Andari Kusmana
CONTACT
C
Cynthia R Retna Sartika, Dr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here